Biofrontera Inc. (NASDAQ:BFRI) Q4 2024 Earnings Conference Call March 21, 2025 10:00 AM ET
Company Participants
Andrew Barwicki – IR Representative
Hermann Luebbert – CEO, Chairman, and Founder
Fred Leffler – CFO
Conference Call Participants
Jonathan Aschoff – Roth Capital
Bruce Jackson – The Benchmark Company
Operator
Good morning and welcome to the Biofrontera Fourth Quarter and Fiscal 2024 Financial Results and Business Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Andrew Barwicki, Investor Relations Representative. Please go ahead.
Andrew Barwicki
Thank you. Good morning and welcome to Biofrontera Incorporated’s fourth quarter and fiscal year 2024 financial results and business update conference call. Actual results may differ materially. Please note that certain information discussed during today’s call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera’s management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company’s business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera’s press releases and SEC filings. Also, this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, March 21, 2025. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.
During today’s call, there will be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors yet should not be considered
Read the full article here